Glenmark Life Sciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar' 24	Dec' 23	Sep' 23	Jun' 23	Mar' 23

Sales

536.60

572.80

595.36

578.45

621.32

Operating profit

141.45

172.56

167.08

193.16

206.43

Interest

0.36

0.39

0.40

0.40

0.12

Gross profit

144.21

173.86

172.05

194.62

209.15

EPS (Rs)

7.99

9.69

9.69

11.05

11.95

Other income

3.13

1.69

5.37

1.85

2.84

Stock adjustment

-9.14

-0.93

3.68

-50.17

-19.37

Raw material

247.84

243.13

269.40

298.21

299.74

Power and fuel

-

-

-

-

-

Employee expenses

72.26

71.05

66.71

48.13

43.81

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

84.20

87.00

88.49

89.12

90.70

Provisions made

-

-

-

-

-

Depreciation

14.53

13.18

13.13

12.61

11.52

Taxation

31.74

41.92

40.19

46.55

51.27

Net profit / loss

97.94

118.77

118.74

135.45

146.36

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

24.51

24.51

24.51

24.51

24.51

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

26.36

30.12

28.06

33.39

33.22

GPM (%)

26.72

30.26

28.64

33.54

33.51

NPM (%)

18.15

20.67

19.77

23.34

23.45